Exercise-Induced Changes in Serum Oncostatin M Levels in Recreationally Active Males
Both Acute Moderate-Intensity Continuous Exercise and High-Intensity Interval Exercise Increase Serum Oncostatin M Levels in Recreationally Active Males
1 other identifier
interventional
15
1 country
1
Brief Summary
The aim of this study was to compare the effects of workload-matched acute moderate-intensity continuous exercise (MICE) and high-intensity interval exercise (HIIE) on serum OSM levels on a cycle ergometer in recreationally active, healthy men. Fifteen participants participated in both MICE and HIIE sessions. The HIIE session consisted of 10 x 1 min intervals at 90% of maximal oxygen uptake (VO2max) separated by a 75-second active recovery period at 60 W, whereas the MICE session consisted of a \~21 min exercise session at 55% of VO2max. Blood samples were collected before (Pre) and immediately after (Post) acute MICE and HIIE sessions. Serum OSM levels were measured by the ELISA method.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 20, 2024
CompletedFirst Submitted
Initial submission to the registry
September 13, 2025
CompletedFirst Posted
Study publicly available on registry
September 26, 2025
CompletedSeptember 26, 2025
September 1, 2025
1 year
September 13, 2025
September 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from Pre- to Post-Exercise Levels of Oncostatin M
Serum samples were collected at pre- and post-exercise time points, and serum oncostatin M levels were measured using a commercial ELISA kit
From baseline assessment of blood samples at pre-exercise to the assessment of blood sample analysis at the end of the post-exercise.
Study Arms (2)
Moderate-intensity continuous exercise (MICE)
EXPERIMENTAL15 recreationally active males completed the \~21 min of exercise at 55% of VO2max, consisting of a 3-minute warm-up and 3-minute cool-down at 60 W.
High-intensity interval exercise (HIIE)
EXPERIMENTAL15 recreationally active males performed 10 x 1-minute intervals at 90% of VO2max, separated by 75 s of active recovery at 60 W, and a final 3-minute cool-down period at 60 W.
Interventions
15 recreationally active males completed the \~21 min of exercise at 55% of VO2max, consisting of a 3-minute warm-up and 3-minute cool-down at 60 W.
15 recreationally active males performed 10 x 1-minute intervals at 90% of VO2max, separated by 75 s of active recovery at 60 W, and a final 3-minute cool-down period at 60 W.
Eligibility Criteria
You may qualify if:
- Engaged in regular exercise/training in the last 6 months,
- years of age,
- Body mass index (BMI) in the range of 18.5-24.9 kg/m².
You may not qualify if:
- Having a chronic disease that limits exercise,
- Smoking,
- Using any medication or supplement that may affect metabolism.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hacettepe University
Ankara, Çankaya, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- LECTURER
Study Record Dates
First Submitted
September 13, 2025
First Posted
September 26, 2025
Study Start
August 1, 2023
Primary Completion
August 1, 2024
Study Completion
September 20, 2024
Last Updated
September 26, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share